Brucellosis Vaccines Market Report

Global Brucellosis Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：211
  • REPORT CODE：GMM831975
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

    Brucellosis Vaccines market report explains the definition, types, applications, major countries, and major players of the Brucellosis Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Qilu

    • Calier & Biologicos Laverlam

    • SYVA Laboratorios

    • Colorado Serum

    • Indian Immunologicals

    • Vetal Company

    • Instituto Rosenbusch

    • Biovet

    • CZ Veterinaria

    • Ceva Sante Animale

    • Onderstepoort Biological

    • Hester Biosciences

    • Jinyu

    • Boehringer Ingelheim

    • Biogenesis-Bago

    • Tecnovax

    • Zoetis

    By Type:

    • S19 Vaccine

    • RB51 Vaccine Strain

    • Other

    By End-User:

    • Cattle

    • Sheep

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Brucellosis Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Brucellosis Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Brucellosis Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Brucellosis Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Brucellosis Vaccines Market- Recent Developments

    • 6.1 Brucellosis Vaccines Market News and Developments

    • 6.2 Brucellosis Vaccines Market Deals Landscape

    7 Brucellosis Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Brucellosis Vaccines Key Raw Materials

    • 7.2 Brucellosis Vaccines Price Trend of Key Raw Materials

    • 7.3 Brucellosis Vaccines Key Suppliers of Raw Materials

    • 7.4 Brucellosis Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Brucellosis Vaccines Cost Structure Analysis

      • 7.5.1 Brucellosis Vaccines Raw Materials Analysis

      • 7.5.2 Brucellosis Vaccines Labor Cost Analysis

      • 7.5.3 Brucellosis Vaccines Manufacturing Expenses Analysis

    8 Global Brucellosis Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Brucellosis Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Brucellosis Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Brucellosis Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Brucellosis Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global S19 Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global RB51 Vaccine Strain Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Brucellosis Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cattle Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Sheep Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Brucellosis Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Brucellosis Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Brucellosis Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Brucellosis Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Brucellosis Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.2 UK Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.5 France Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Brucellosis Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Brucellosis Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.3 India Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Brucellosis Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Brucellosis Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Brucellosis Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Brucellosis Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Brucellosis Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Brucellosis Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Brucellosis Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Brucellosis Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Brucellosis Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Brucellosis Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Brucellosis Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Brucellosis Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Brucellosis Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Brucellosis Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Brucellosis Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Brucellosis Vaccines Consumption (2017-2022)

    11 Global Brucellosis Vaccines Competitive Analysis

    • 11.1 Qilu

      • 11.1.1 Qilu Company Details

      • 11.1.2 Qilu Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Qilu Brucellosis Vaccines Main Business and Markets Served

      • 11.1.4 Qilu Brucellosis Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Calier & Biologicos Laverlam

      • 11.2.1 Calier & Biologicos Laverlam Company Details

      • 11.2.2 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Calier & Biologicos Laverlam Brucellosis Vaccines Main Business and Markets Served

      • 11.2.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 SYVA Laboratorios

      • 11.3.1 SYVA Laboratorios Company Details

      • 11.3.2 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 SYVA Laboratorios Brucellosis Vaccines Main Business and Markets Served

      • 11.3.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Colorado Serum

      • 11.4.1 Colorado Serum Company Details

      • 11.4.2 Colorado Serum Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Colorado Serum Brucellosis Vaccines Main Business and Markets Served

      • 11.4.4 Colorado Serum Brucellosis Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Indian Immunologicals

      • 11.5.1 Indian Immunologicals Company Details

      • 11.5.2 Indian Immunologicals Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Indian Immunologicals Brucellosis Vaccines Main Business and Markets Served

      • 11.5.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Vetal Company

      • 11.6.1 Vetal Company Company Details

      • 11.6.2 Vetal Company Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Vetal Company Brucellosis Vaccines Main Business and Markets Served

      • 11.6.4 Vetal Company Brucellosis Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Instituto Rosenbusch

      • 11.7.1 Instituto Rosenbusch Company Details

      • 11.7.2 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Instituto Rosenbusch Brucellosis Vaccines Main Business and Markets Served

      • 11.7.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Biovet

      • 11.8.1 Biovet Company Details

      • 11.8.2 Biovet Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Biovet Brucellosis Vaccines Main Business and Markets Served

      • 11.8.4 Biovet Brucellosis Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 CZ Veterinaria

      • 11.9.1 CZ Veterinaria Company Details

      • 11.9.2 CZ Veterinaria Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 CZ Veterinaria Brucellosis Vaccines Main Business and Markets Served

      • 11.9.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Ceva Sante Animale

      • 11.10.1 Ceva Sante Animale Company Details

      • 11.10.2 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Ceva Sante Animale Brucellosis Vaccines Main Business and Markets Served

      • 11.10.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Onderstepoort Biological

      • 11.11.1 Onderstepoort Biological Company Details

      • 11.11.2 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Onderstepoort Biological Brucellosis Vaccines Main Business and Markets Served

      • 11.11.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Hester Biosciences

      • 11.12.1 Hester Biosciences Company Details

      • 11.12.2 Hester Biosciences Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Hester Biosciences Brucellosis Vaccines Main Business and Markets Served

      • 11.12.4 Hester Biosciences Brucellosis Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Jinyu

      • 11.13.1 Jinyu Company Details

      • 11.13.2 Jinyu Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Jinyu Brucellosis Vaccines Main Business and Markets Served

      • 11.13.4 Jinyu Brucellosis Vaccines Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Boehringer Ingelheim

      • 11.14.1 Boehringer Ingelheim Company Details

      • 11.14.2 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Boehringer Ingelheim Brucellosis Vaccines Main Business and Markets Served

      • 11.14.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Biogenesis-Bago

      • 11.15.1 Biogenesis-Bago Company Details

      • 11.15.2 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Biogenesis-Bago Brucellosis Vaccines Main Business and Markets Served

      • 11.15.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Tecnovax

      • 11.16.1 Tecnovax Company Details

      • 11.16.2 Tecnovax Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Tecnovax Brucellosis Vaccines Main Business and Markets Served

      • 11.16.4 Tecnovax Brucellosis Vaccines Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Zoetis

      • 11.17.1 Zoetis Company Details

      • 11.17.2 Zoetis Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Zoetis Brucellosis Vaccines Main Business and Markets Served

      • 11.17.4 Zoetis Brucellosis Vaccines Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    12 Global Brucellosis Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Brucellosis Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global S19 Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global RB51 Vaccine Strain Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Brucellosis Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Cattle Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Sheep Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Brucellosis Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Brucellosis Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Brucellosis Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Brucellosis Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Brucellosis Vaccines

    • Figure of Brucellosis Vaccines Picture

    • Table Global Brucellosis Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Brucellosis Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global S19 Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global RB51 Vaccine Strain Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Cattle Consumption and Growth Rate (2017-2022)

    • Figure Global Sheep Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Brucellosis Vaccines Consumption by Country (2017-2022)

    • Table North America Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure United States Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure Germany Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure China Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Brucellosis Vaccines Consumption by Country (2017-2022)

    • Figure Australia Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Brucellosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Qilu Company Details

    • Table Qilu Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Brucellosis Vaccines Main Business and Markets Served

    • Table Qilu Brucellosis Vaccines Product Portfolio

    • Table Calier & Biologicos Laverlam Company Details

    • Table Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Calier & Biologicos Laverlam Brucellosis Vaccines Main Business and Markets Served

    • Table Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio

    • Table SYVA Laboratorios Company Details

    • Table SYVA Laboratorios Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table SYVA Laboratorios Brucellosis Vaccines Main Business and Markets Served

    • Table SYVA Laboratorios Brucellosis Vaccines Product Portfolio

    • Table Colorado Serum Company Details

    • Table Colorado Serum Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Colorado Serum Brucellosis Vaccines Main Business and Markets Served

    • Table Colorado Serum Brucellosis Vaccines Product Portfolio

    • Table Indian Immunologicals Company Details

    • Table Indian Immunologicals Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Indian Immunologicals Brucellosis Vaccines Main Business and Markets Served

    • Table Indian Immunologicals Brucellosis Vaccines Product Portfolio

    • Table Vetal Company Company Details

    • Table Vetal Company Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vetal Company Brucellosis Vaccines Main Business and Markets Served

    • Table Vetal Company Brucellosis Vaccines Product Portfolio

    • Table Instituto Rosenbusch Company Details

    • Table Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Instituto Rosenbusch Brucellosis Vaccines Main Business and Markets Served

    • Table Instituto Rosenbusch Brucellosis Vaccines Product Portfolio

    • Table Biovet Company Details

    • Table Biovet Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biovet Brucellosis Vaccines Main Business and Markets Served

    • Table Biovet Brucellosis Vaccines Product Portfolio

    • Table CZ Veterinaria Company Details

    • Table CZ Veterinaria Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CZ Veterinaria Brucellosis Vaccines Main Business and Markets Served

    • Table CZ Veterinaria Brucellosis Vaccines Product Portfolio

    • Table Ceva Sante Animale Company Details

    • Table Ceva Sante Animale Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ceva Sante Animale Brucellosis Vaccines Main Business and Markets Served

    • Table Ceva Sante Animale Brucellosis Vaccines Product Portfolio

    • Table Onderstepoort Biological Company Details

    • Table Onderstepoort Biological Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Onderstepoort Biological Brucellosis Vaccines Main Business and Markets Served

    • Table Onderstepoort Biological Brucellosis Vaccines Product Portfolio

    • Table Hester Biosciences Company Details

    • Table Hester Biosciences Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hester Biosciences Brucellosis Vaccines Main Business and Markets Served

    • Table Hester Biosciences Brucellosis Vaccines Product Portfolio

    • Table Jinyu Company Details

    • Table Jinyu Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jinyu Brucellosis Vaccines Main Business and Markets Served

    • Table Jinyu Brucellosis Vaccines Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Brucellosis Vaccines Main Business and Markets Served

    • Table Boehringer Ingelheim Brucellosis Vaccines Product Portfolio

    • Table Biogenesis-Bago Company Details

    • Table Biogenesis-Bago Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogenesis-Bago Brucellosis Vaccines Main Business and Markets Served

    • Table Biogenesis-Bago Brucellosis Vaccines Product Portfolio

    • Table Tecnovax Company Details

    • Table Tecnovax Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tecnovax Brucellosis Vaccines Main Business and Markets Served

    • Table Tecnovax Brucellosis Vaccines Product Portfolio

    • Table Zoetis Company Details

    • Table Zoetis Brucellosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zoetis Brucellosis Vaccines Main Business and Markets Served

    • Table Zoetis Brucellosis Vaccines Product Portfolio

    • Figure Global S19 Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global RB51 Vaccine Strain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cattle Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sheep Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Brucellosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Brucellosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US